Your browser doesn't support javascript.
loading
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function.
Jain, Sunil M; Balamurugan, Ramanathan; Tandon, Monika; Mozaffarian, Neelufar; Gudi, Girish; Salhi, Yacine; Holland, Robert; Freeman, Roy; Baron, Ralf.
Afiliación
  • Jain SM; TOTALL Diabetes Hormone Institute, Indore, India.
  • Balamurugan R; Kovai Diabetes Speciality Centre and Hospital, Coimbatore, India.
  • Tandon M; Clinical Sciences, Glenmark Pharmaceuticals Limited, Mumbai, India.
  • Mozaffarian N; Janssen Pharmaceuticals, Inc, Cambridge, MA, United States.
  • Gudi G; Ichnos Sciences, Inc, New York, NY, United States.
  • Salhi Y; Ichnos Sciences, Inc, New York, NY, United States.
  • Holland R; Early Clinical Development Consulting Ltd, Macclesfield, United Kingdom.
  • Freeman R; Department of Neurology, Harvard Medical School, Boston, MA, United States.
  • Baron R; Division of Neurological Pain Research and Therapy, Universitätsklinikum Schleswig-Holstein, Campus-Kiel, Germany.
Pain ; 163(6): e738-e747, 2022 06 01.
Article en En | MEDLINE | ID: mdl-34490850

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus / Neuropatías Diabéticas / Dolor Crónico / Neuralgia Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Pain Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus / Neuropatías Diabéticas / Dolor Crónico / Neuralgia Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Pain Año: 2022 Tipo del documento: Article País de afiliación: India